Announcements Trials
Browse Landscape

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Breast Neoplasms 2Triple Negative Breast Neoplasms 1Kidney Neoplasms 1

Interventions

Ipilimumab 5pembrolizumab 4Axitinib 4cabozantinib 3Nivolumab 3Blood Specimen Collection 3zimberelimab 2atezolizumab 2Surveys and Questionnaires 2Sunitinib 2Irinotecan 2trebananib 1temsirolimus 1spartalizumab 1salicylhydroxamic acid 1palbociclib 1orellanine 1olaparib 1liposomal doxorubicin 1lenvatinib 1gallium Ga 68 dotatate 1fludarabine 1brodalumab 1belzutifan 1aldesleukin 1adagrasib 1X-Rays 1Vincristine 1Temozolomide 1Technetium Tc 99m Sestamibi 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Kidney Neoplasms × Technetium Tc 99m Sestamibi × 90 days × Clear all
NCT03996850 2026-03-13

SPECT/CT for the Characterization of Renal Masses

Jonsson Comprehensive Cancer Center

Active not recruiting
102 enrolled
Genitourinary

Kidney Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡